Crinetics Pharmaceuticals Inc (CRNX)
EBITDA
-$131.39M
Quarterly · Period ending: · USD
CRNX EBITDA
Latest reported-$131.39Mperiod ending
Latest reported-$131.39Mperiod ending
CRNX Quarterly EBITDA (-$2.58M → -$131.39M)
Quarterly EBITDA
High-resolution chart · PNG
CRNX ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -131,386,000 | |
| -126,685,000 | |
| -121,641,000 | |
| -129,079,000 | |
| -114,678,000 | |
| -95,849,000 | |
| -79,807,000 | |
| -76,058,000 | |
| -73,302,000 | |
| -66,456,000 | |
| -59,835,000 | |
| -57,185,000 | |
| -50,699,000 | |
| -45,712,000 | |
| -44,711,000 | |
| -41,677,000 | |
| -42,160,000 | |
| -34,387,000 | |
| -30,559,000 | |
| -27,618,000 | |
| -25,865,000 | |
| -22,694,000 | |
| -21,566,000 | |
| -18,207,000 | |
| -16,685,000 | |
| -17,547,000 | |
| -14,985,000 | |
| -15,001,000 | |
| -13,115,000 | |
| -9,844,000 | |
| -8,287,000 | |
| -7,931,000 | |
| -5,607,000 | |
| -5,478,000 | |
| -2,472,000 | |
| -2,352,000 | |
| -1,620,000 | |
| -2,577,000 |